Literature DB >> 8602365

Psoralen crosslinking between human immunodeficiency virus type 1 RNA and primer tRNA3(Lys).

E Skripkin1, C Isel, R Marquet, B Ehresmann, C Ehresmann.   

Abstract

Initiation of reverse transcription is a crucial step of retroviral infection. In HIV-1, it involves hybridization of the 18 3'-terminal nucleotides of the primer tRNA3(Lys) to the primer binding site (PBS) of the viral RNA. Moreover, additional interactions between the two RNAs were recently evidenced [Isel et al. (1995) J. Mol. Biol. 247, 25269-25272]. To get further information on the topology of the viral RNA/tRNA3(Lys) complex, we used psoralen to induce RNA-RNA crosslinking. A defined intermolecular crosslinked complex was obtained. The crosslinked regions were characterized by RNase T1 digestion followed by bi-dimensional gel electrophoresis. The crosslinked residues (nucleotide mcm5S2U34 and U35 in the anticodon loop of tRNA3(Lys) and UCU154 in the viral RNA upstream of the PBS) were mapped using a retardation method coupled with random hydrolysis. The formation of this crosslink depends on the same elements that are required for the formation of the extended interactions between primer and template RNAs, i.e., the modified bases of the tRNA and a conserved A-rich loop located upstream of the PBS in the genomic RNA. Therefore, the present crosslinking data provide relevant information on the topology of the template/primer binary complex.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8602365      PMCID: PMC145650          DOI: 10.1093/nar/24.3.509

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  25 in total

1.  A new interaction between the mouse 5' external transcribed spacer of pre-rRNA and U3 snRNA detected by psoralen crosslinking.

Authors:  K Tyc; J A Steitz
Journal:  Nucleic Acids Res       Date:  1992-10-25       Impact factor: 16.971

2.  Interaction between retroviral U5 RNA and the T psi C loop of the tRNA(Trp) primer is required for efficient initiation of reverse transcription.

Authors:  A Aiyar; D Cobrinik; Z Ge; H J Kung; J Leis
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

3.  Variable tRNA content in HIV-1IIIB.

Authors:  M Jiang; J Mak; M A Wainberg; M A Parniak; E Cohen; L Kleiman
Journal:  Biochem Biophys Res Commun       Date:  1992-06-30       Impact factor: 3.575

4.  A specific orientation of RNA secondary structures is required for initiation of reverse transcription.

Authors:  A Aiyar; Z Ge; J Leis
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

5.  Modified nucleotides of tRNA(3Lys) modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription.

Authors:  C Isel; R Marquet; G Keith; C Ehresmann; B Ehresmann
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

6.  Psoralen crosslinking of small RNAs in vitro.

Authors:  D A Wassarman
Journal:  Mol Biol Rep       Date:  1993-02       Impact factor: 2.316

7.  Identification of a small RNA that interacts with the 5' splice site of the Trypanosoma brucei spliced leader RNA in vivo.

Authors:  K P Watkins; J M Dungan; N Agabian
Journal:  Cell       Date:  1994-01-14       Impact factor: 41.582

8.  Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1.

Authors:  M Jiang; J Mak; A Ladha; E Cohen; M Klein; B Rovinski; L Kleiman
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitro.

Authors:  E Skripkin; J C Paillart; R Marquet; B Ehresmann; C Ehresmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

10.  Dimerization of human immunodeficiency virus type 1 RNA involves sequences located upstream of the splice donor site.

Authors:  R Marquet; J C Paillart; E Skripkin; C Ehresmann; B Ehresmann
Journal:  Nucleic Acids Res       Date:  1994-01-25       Impact factor: 16.971

View more
  19 in total

1.  Initiation of HIV-2 reverse transcription: a secondary structure model of the RNA-tRNA(Lys3) duplex.

Authors:  F Freund; F Boulmé; S Litvak; L Tarrago-Litvak
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

2.  The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity.

Authors:  C Liang; X Li; L Rong; P Inouye; Y Quan; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1.

Authors:  X Li; C Liang; Y Quan; R Chandok; M Laughrea; M A Parniak; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Human immunodeficiency virus type-1 reverse transcription can be inhibited in vitro by oligonucleotides that target both natural and synthetic tRNA primers.

Authors:  X Wei; M Götte; M A Wainberg
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

5.  Does the HIV-1 primer activation signal interact with tRNA3(Lys) during the initiation of reverse transcription?

Authors:  Valérie Goldschmidt; Chantal Ehresmann; Bernard Ehresmann; Roland Marquet
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

6.  Structure-function relationships of the initiation complex of HIV-1 reverse transcription: the case of mutant viruses using tRNA(His) as primer.

Authors:  Mickaël Rigourd; Valérie Goldschmidt; Fabienne Brulé; Casey D Morrow; Bernard Ehresmann; Chantal Ehresmann; Roland Marquet
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

7.  Mutational analysis of the tRNA3Lys/HIV-1 RNA (primer/template) complex.

Authors:  C Isel; G Keith; B Ehresmann; C Ehresmann; R Marquet
Journal:  Nucleic Acids Res       Date:  1998-03-01       Impact factor: 16.971

8.  Two step synthesis of (-) strong-stop DNA by avian and murine reverse transcriptases in vitro.

Authors:  C Isel; C Ehresmann; G Keith; B Ehresmann; R Marquet
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

9.  Use of terbium as a probe of tRNA tertiary structure and folding.

Authors:  M R Hargittai; K Musier-Forsyth
Journal:  RNA       Date:  2000-11       Impact factor: 4.942

10.  HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation.

Authors:  Gaëlle Mercenne; Serena Bernacchi; Delphine Richer; Guillaume Bec; Simon Henriet; Jean-Christophe Paillart; Roland Marquet
Journal:  Nucleic Acids Res       Date:  2009-11-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.